Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Etamsylate

EU orphan designation number: EU/3/18/2087   
Active ingredient: Etamsylate
Indication: Treatment of hereditary haemorrhagic telangiectasia
Sponsor: Consejo Superior de Investigaciones Cientificas (CSIC)
C/ Serrano 142, 28006 Madrid, España

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2018 Orphan designation EMA/OD/135/18 (2018)7796 of 19/11/2018